Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$0.53 - $0.93 $43 - $77
83 Added 0.26%
32,283 $18,000
Q4 2023

Feb 13, 2024

SELL
$0.63 - $1.14 $415 - $752
-660 Reduced 2.01%
32,200 $26,000
Q2 2023

Aug 09, 2023

BUY
$1.31 - $2.04 $7,729 - $12,036
5,900 Added 21.88%
32,860 $52,000
Q3 2022

Nov 10, 2022

BUY
$1.96 - $3.14 $33,241 - $53,254
16,960 Added 169.6%
26,960 $55,000
Q4 2021

Feb 14, 2022

BUY
$2.92 - $5.74 $29,200 - $57,400
10,000 New
10,000 $32,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.